Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

URGN

UroGen Pharma Ltd

May 22 • 04:00PM ET

28.89

-0.99 -3.31 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IBRX TARA CGEN VERU FATE

| Held by: IWM IBB IWO SPDW FESM VTWO IWC IZRL VHT IWN

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.75	Insider Own	20.83%	Shs Outstand	48.71M	Perf Week	0.38%
Market Cap	1.41B	Forward P/E	20.11	EPS next Y	1.44	Insider Trans	-0.24%	Shs Float	38.46M	Perf Month	18.84%
Enterprise Value	1.46B	PEG	-	EPS next Q	-0.29	Inst Own	87.36%	Short Float	18.82%	Perf Quarter	38.10%
Income	-133.23M	P/S	10.02	EPS this Y	72.25%	Inst Trans	1.01%	Short Ratio	8.23	Perf Half Y	14.33%
Sales	140.49M	P/B	-	EPS next Y	262.32%	ROA	-53.15%	Short Interest	7.24M	Perf YTD	23.36%
Book/sh	-2.55	P/C	9.94	EPS next 5Y	-	ROE	-	52W High	32.37 -10.75%	Perf Year	608.09%
Cash/sh	2.91	P/FCF	-	EPS past 3/5Y	12.81% 11.57%	ROIC	-187.84%	52W Low	3.61 701.39%	Perf 3Y	151.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	19.49% 56.22%	Gross Margin	89.85%	Volatility	5.27% 6.78%	Perf 5Y	55.91%
Dividend TTM	-	EV/Sales	10.41	EPS Y/Y TTM	13.32%	Oper. Margin	-77.02%	ATR (14)	1.80	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.28	Sales Y/Y TTM	52.92%	Profit Margin	-94.83%	RSI (14)	59.29	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	4.69	EPS Q/Q	49.18%	SMA20	6.26%	Beta	1.61	Target Price	36.11
Payout	-	Debt/Eq	-	Sales Q/Q	151.60%	SMA50	26.23%	Rel Volume	0.40	Prev Close	29.88
Employees	291	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	36.14%	Avg Volume	879.74K	Price	28.89
IPO	May 04, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.57% 13.68%	Trades		Volume	348,534	Change	-3.31%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)